Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.
about
HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity.Guide to Enantioselective Dirhodium(II)-Catalyzed Cyclopropanation with AryldiazoacetatesWe Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.Synthesis and biological evaluation of neopeltolide and analogsDiscovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches.Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.5-HT2C receptor modulators: a patent survey.Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?Superoxide chemistry revisited: synthesis of tetrachloro-substituted methylenenortricyclenes.Design, synthesis and biological evaluation of GPR55 agonists.
P2860
Q30478847-4B70A5D8-9A07-43AA-97C7-0605FFBBDB3FQ34332000-D101C082-CA59-48FA-8583-D8341D661EFCQ35052327-4DC17272-1856-4268-A388-5150ACE7692BQ35823591-B66BE8E3-879E-4965-82C4-4154D2FB45BDQ35841039-A9E6CF30-2DAA-468C-BE94-F9DAE295E3CDQ36053050-E0EB0060-E23B-4637-9365-67CD7E21098CQ36805380-528BAB97-F7C0-4E5C-BB67-3F6809216D87Q37789738-D5FB353E-0F15-434A-9438-6E095C074349Q37834732-7AED9139-A86C-4398-B6E0-5DEAB454599EQ38034731-BBB900C5-9DDF-45FD-9F69-731CA2E10837Q39768889-0C869B2E-8339-4730-AC4B-27BDC2D4DBECQ42052350-71423BC6-C8C8-452A-92D3-C347AB488A34Q50909760-4412839C-D65D-4D64-98D6-80DD78999058
P2860
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@ast
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@en
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@nl
type
label
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@ast
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@en
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@nl
prefLabel
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@ast
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@en
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@nl
P2093
P2860
P356
P1476
Selective 5-hydroxytryptamine ...... th antidepressant-like action.
@en
P2093
Alan P Kozikowski
Barbara Caldarone
Bryan L Roth
Jessica E Malberg
Michael L Manzano
Niels H Jensen
Sudhakar Kadari
Sung Jin Cho
Toru Kurome
P2860
P304
P356
10.1021/JM801354E
P407
P577
2009-04-01T00:00:00Z